Aroa Biosurgery Limited
ASX:ARX.AX
0.56 (AUD) • At close November 5, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) AUD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|
| Revenue
| 64.022 | 59.309 | 36.881 | 20.51 | 23.827 | 21.766 | 9.663 |
| Cost of Revenue
| 9.369 | 9.252 | 8.715 | 6.259 | 6.33 | 8.036 | 5.454 |
| Gross Profit
| 54.653 | 50.057 | 28.165 | 14.251 | 17.497 | 13.73 | 4.209 |
| Gross Profit Ratio
| 0.854 | 0.844 | 0.764 | 0.695 | 0.734 | 0.631 | 0.436 |
| Reseach & Development Expenses
| 8.49 | 9.934 | 7.765 | 5.898 | 4.484 | 4.072 | 2.89 |
| General & Administrative Expenses
| 0.598 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling & Marketing Expenses
| 57.012 | 44.659 | 28.542 | 19.975 | 0 | 0 | 0 |
| SG&A
| 57.61 | 44.659 | 28.542 | 19.975 | 15.839 | 9.836 | 3.559 |
| Other Expenses
| 1.712 | 3.304 | 1.16 | -4.305 | 0 | 0 | 0 |
| Operating Expenses
| 66.1 | 58.187 | 39.216 | 28.7 | 20.322 | 13.909 | 6.448 |
| Operating Income
| -11.447 | -0.354 | -6.981 | -16.158 | -2.826 | -0.179 | -2.239 |
| Operating Income Ratio
| -0.179 | -0.006 | -0.189 | -0.788 | -0.119 | -0.008 | -0.232 |
| Total Other Income Expenses Net
| 0.273 | 3.304 | 1.16 | -4.305 | -3.027 | -2.665 | 0.776 |
| Income Before Tax
| -11.175 | -0.359 | -7.678 | -17.536 | -5.853 | -2.845 | -1.463 |
| Income Before Tax Ratio
| -0.175 | -0.006 | -0.208 | -0.855 | -0.246 | -0.131 | -0.151 |
| Income Tax Expense
| -1.323 | 0.011 | 0.116 | 0.098 | -0.192 | -3.741 | -0.285 |
| Net Income
| -9.852 | -0.371 | -7.794 | -17.634 | -5.661 | 0.896 | -1.179 |
| Net Income Ratio
| -0.154 | -0.006 | -0.211 | -0.86 | -0.238 | 0.041 | -0.122 |
| EPS
| -0.029 | -0.001 | -0.023 | -0.059 | -0.019 | 0.003 | -0.004 |
| EPS Diluted
| -0.029 | -0.001 | -0.023 | -0.059 | -0.019 | 0.003 | -0.004 |
| EBITDA
| -7.36 | 3.241 | -4.071 | -13.331 | -0.219 | 1.748 | -1.558 |
| EBITDA Ratio
| -0.115 | 0.055 | -0.11 | -0.65 | -0.009 | 0.08 | -0.161 |